1Kyushu Central Hospital.
Selective estrogen receptor modulators (SERMs) offer therapeutic potential for postmenopausal osteoporosis. Raloxifene is a recommended SERM for managing osteoporosis in middle-aged postmenopausal women due to its safety profile.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Context:
Purpose:
Summary:
Impact: